Study: Progression of cardiodiabesity increases care utilization and costs
The Evernorth Research Institute’s latest cardiodiabesity report helps illustrate sites of care where preventive interventions can make the greatest financial impact.
Read More
Understanding cardiodiabesity in women
As employers strive to maintain a healthy and productive workforce, addressing and understanding the prevalence of cardiodiabesity in women is critical.
Read More
Enhancing health outcomes and savings through value-based solutions
Patient engagement paired with cost-containment strategies drives better health outcomes and reduces the financial burden for plan sponsors.
Read More
GLP-1s and digital support: A winning combination
When GLP-1s aren’t enough, lifestyle modification can be key to weight management.
Read More
Easing the impact of GLP-1s
With GLP-1 sales forecast to exceed $100 billion, plan sponsors need the tools to control growth and expand access.
Read More
Chronic conditions: The impact of delayed detection
Early detection of chronic diseases matters to the bottom line.
Read More